Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-033948
Filing Date
2024-11-07
Accepted
2024-11-07 16:33:58
Documents
72
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tgtx20240930_10q.htm   iXBRL 10-Q 1763814
2 EXHIBIT 10.1 ex_741510.htm EX-10.1 577577
3 EXHIBIT 31.1 ex_716997.htm EX-31.1 12340
4 EXHIBIT 31.2 ex_716998.htm EX-31.2 12684
5 EXHIBIT 32.1 ex_716999.htm EX-32.1 5754
6 EXHIBIT 32.2 ex_717000.htm EX-32.2 6071
12 f01.jpg GRAPHIC 55134
13 f02.jpg GRAPHIC 5801
14 fujifilm01.jpg GRAPHIC 11402
  Complete submission text file 0001437749-24-033948.txt   7801176

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20240930.xsd EX-101.SCH 57304
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20240930_cal.xml EX-101.CAL 44053
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20240930_def.xml EX-101.DEF 405465
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20240930_lab.xml EX-101.LAB 352994
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20240930_pre.xml EX-101.PRE 433047
75 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20240930_10q_htm.xml XML 961422
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 241436422
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)